Atlas Trials

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Clinical trial NCT02827838 · TERMINATED

Trial details

NCT number
NCT02827838
Sponsor
Wake Forest University Health Sciences
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Oral Cavity Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Oral Cavity Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell CarcinomaStage IVC Oropharyngeal Squamous Cell Carcinoma
Start date
2017-01-01
Primary completion
2022-04-22
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.